Cerebral venous thrombosis and activated protein C resistance

Stroke. 1996 Oct;27(10):1731-3. doi: 10.1161/01.str.27.10.1731.

Abstract

Background: Activated protein C resistance (APC-R) due to factor V Leiden has recently been established as an important risk factor for cerebral venous thrombosis (CVT). The clinical significance of abnormal or borderline functional APC-R in the absence of factor V Leiden is uncertain. Our observations suggest that APC-R due to mechanisms other than factor V Leiden may also contribute to the development of CVT.

Case descriptions: We describe three women who had superior sagittal and lateral sinus thrombosis while taking oral contraceptives and had a number of additional risk factors for CVT. Each had APC-R for different reasons.

Conclusions: Inherited thrombophilia, including APC-R, should be looked for in all patients with CVT. Functional APC-R is a highly prevalent coagulopathy, but the reasons for this abnormality are diverse; abnormal and borderline functional APC-R results should be supplemented by DNA analysis for the presence of factor V Leiden.

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Cerebral Veins
  • Contraceptives, Oral / adverse effects
  • Drug Resistance
  • Female
  • Humans
  • Intracranial Embolism and Thrombosis / drug therapy
  • Intracranial Embolism and Thrombosis / physiopathology*
  • Partial Thromboplastin Time
  • Protein C / analysis
  • Protein C / physiology*
  • Protein S / analysis
  • Risk Factors
  • Sinus Thrombosis, Intracranial / drug therapy
  • Sinus Thrombosis, Intracranial / etiology
  • Sinus Thrombosis, Intracranial / physiopathology
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Contraceptives, Oral
  • Protein C
  • Protein S
  • Warfarin